The 3 Bs of cancer care amid the COVID‐19 pandemic crisis: “Be safe, be smart, be kind”—A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer
Jung Julie Kang, Richard J. Wong, Eric J. Sherman, A. Rybkin, Sean M. McBride, Nadeem Riaz, C. Jillian Tsai, Yao Yu, Linda Chen, Kaveh Zakeri, Daphna Y. Gelblum, Erin F. Gillespie, Marc A. Cohen, Jennifer R. Cracchiolo, Ian Ganly, Snehal G. Patel, Bhuvanesh Singh, Jay O. Boyle, Benjamin R. Roman, Luc G.T. Morris, Ashok R. Shaha, Lara Dunn, Alan L. Ho, James Fetten, Jatin P. Shah, David G. Pfister, Nancy Y. Lee
Abstract
Because of the national emergency triggered by the coronavirus disease 2019 (COVID-19) pandemic, government-mandated public health directives have drastically changed not only social norms but also the practice of oncologic medicine. Timely head and neck cancer (HNC) treatment must be prioritized, even during emergencies. Because severe acute respiratory syndrome coronavirus 2 predominantly resides in the sinonasal/oral/oropharyngeal tracts, nonessential mucosal procedures are restricted, and HNCs are being triaged toward nonsurgical treatments when cures are comparable. Consequently, radiation utilization will likely increase during this pandemic. Even in radiation oncology, standard in-person and endoscopic evaluations are being restrained to limit exposure risks and preserve personal protective equipment for other frontline workers. The authors have implemented telemedicine and multidisciplinary conferences to continue to offer standard-of-care HNC treatments during this uniquely challenging time. Because of the lack of feasibility data on telemedicine for HNC, they report their early experience at a high-volume cancer center at the domestic epicenter of the COVID-19 crisis.